Table 5.
Univariate and multivariate analyses of risk factors for postoperative mortality
Variable | Univariate analysis |
Multivariate analysis |
|
---|---|---|---|
P Value |
Odds ratio (95% Confidence interval) |
P Value |
|
Demographics | |||
Age (years)a | 0.085 | 0.410 | |
Female sex (yes vs no) | 0.006 | 0.471 | |
Clinical variables | |||
Cirrhosis (yes vs no) | 0.024 | 0.252 | |
Portal hypertension (yes vs no) | 0.475 | ||
ASA ≥ III (yes vs no) | 0.007 | 0.880 | |
Chronic pulmonary disease (yes vs no) | 0.698 | ||
Cardiovascular disease (yes vs no) | 0.004 | 0.190 | |
Diabetes mellitus (yes vs no) | 0.090 | 3.2 (1.3–8.2) | 0.015 |
Chronic kidney injury (yes vs no) | 0.017 | 0.500 | |
Body mass index ≥ 30 kg/m2 (yes vs no) | 0.359 | ||
eGFR (ml/min/1.73 m2)a | 0.778 | ||
MELD scorea | <0.002 | 1.2 (1.0–1.3) | 0.018 |
BCLC stage (A vs B or C) | 0.006 | 0.459 | |
Intra-operative variables | |||
Extent of liver resection (minor vs major) | 0.082 | 0.768 | |
Vascular clamping (yes vs no) | 0.027 | 0.633 | |
Clamping time (min)a | 0.053 | 0.995 | |
Packed red blood cell transfusion (yes vs no) | <0.001 | 2.9 (1.2–6.7) | 0.016 |
Duration of operation > 300 min (yes vs no) | 0.37 | ||
Complications | |||
AKI (yes vs no) | <0.001 | 6.6 (2.8–15.5) | <0.001 |
Liver failure (yes vs no) | <0.001 | 5.7 (1.8–17.6) | 0.003 |
Ascites (yes vs no) | <0.001 | 0.785 | |
Biliary fistula (yes vs no) | 0.952 | ||
Infectious complications (yes vs no) | <0.001 | 0.696 | |
Pulmonary complications (yes vs no) | <0.005 | 0.593 |
Footnotes: ASA, American Society of Anesthesiologists; eGFR, estimated glomerular filtration rate; APRI, aminoaspartate transferase to platelet ratio index; MELD, Model for End-stage Liver Disease; BCLC, Barcelona Clinic Liver Cancer; AKI, acute kidney injury; KDIGO, Kidney Disease Improving Global Outcomes.
Continuous variables.